BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 508534)

  • 1. Interaction of desipramine and ciclazindol with adrenergic mechanisms in the human iris [proceedings].
    Kerr FA; Szabadi E
    Br J Clin Pharmacol; 1979 Oct; 8(4):396P-397P. PubMed ID: 508534
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of chronic administration of ciclazindol and desipramine on pupillary responses to tyramine, methoxamine and pilocarpine in healthy volunteers.
    Kerr FA; Szabadi E
    Br J Clin Pharmacol; 1985 May; 19(5):639-47. PubMed ID: 4005103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and autonomic actions of ciclazindol and tricyclic antidepressants.
    Waterfall JF; Smith MA; Gaston WH; Maher J; Warburton G
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):116-36. PubMed ID: 507990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic mechanisms in diet-induced thermogenesis: modification by ciclazindol and anorectic drugs.
    Rothwell NJ; Stock MJ; Wyllie MG
    Br J Pharmacol; 1981 Nov; 74(3):539-46. PubMed ID: 6271318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do tricyclic antidepressants enhance adrenergic transmission? An update.
    Heydorn W; Frazer A; Mendels J
    Am J Psychiatry; 1980 Jan; 137(1):113-4. PubMed ID: 6243449
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
    Crews FT; Smith CB
    J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ciclazindol on monoamine uptake and CNS function in normal subjects.
    Oh VM; Ehsanullah RS; Leighton M; Kirby MJ
    Psychopharmacology (Berl); 1979 Jan; 60(2):177-81. PubMed ID: 106428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between alpha-methyl-dopa and tricyclic antidepressants.
    van Spanning HW; van Zwieten PA
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):65-7. PubMed ID: 1150364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
    Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ
    Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
    Malmors T; Abrams WB
    J Pharmacol Exp Ther; 1970 Jul; 174(1):99-110. PubMed ID: 4316536
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of the beta-adrenergic receptor-adenylate cyclase system following acute and repeated treatment with antidepressants.
    Weiss B; Heydorn W; Frazer A
    Adv Biochem Psychopharmacol; 1982; 31():37-53. PubMed ID: 6282063
    [No Abstract]   [Full Text] [Related]  

  • 12. Some clinical pharmacological studies with ciclazindol hydrochloride [proceedings].
    Ehsanullah RS; Kirby MJ; Leighton M; Oh VM
    Br J Clin Pharmacol; 1977 Jun; 4(3):400P. PubMed ID: 901726
    [No Abstract]   [Full Text] [Related]  

  • 13. [De- and regeneration of adrenergic nerves in the rat iris following administration of toxic false transmitters].
    Groth HP
    Verh Anat Ges; 1974; 68():353-61. PubMed ID: 4467601
    [No Abstract]   [Full Text] [Related]  

  • 14. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
    Reynolds JL; Ignatowski TA; Sud R; Spengler RN
    Neuroscience; 2005; 133(2):519-31. PubMed ID: 15878644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium.
    Luthman J; Jonsson G
    Med Biol; 1986; 64(2-3):95-102. PubMed ID: 3489145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potentialisation by desipramine of adrenergic sensitization by pyrogallol].
    Caillard C; Rossignol P; Valette G
    C R Seances Soc Biol Fil; 1969; 163(1):70-3. PubMed ID: 4241438
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonism by tricyclic antidepressants of the muscarinic receptors located on the adrenergic nerve endings in rabbit heart atrium.
    Somogyi GT; Perel JM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):922-8. PubMed ID: 2600822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degeneration of adrenergic nerves produced by 6-hydroxydopamine.
    Sachs C
    Br J Pharmacol; 1968 Sep; 34(1):224P. PubMed ID: 5692085
    [No Abstract]   [Full Text] [Related]  

  • 19. Guanethidine.
    Woosley RL; Nies AS
    N Engl J Med; 1976 Nov; 295(19):1053-7. PubMed ID: 972658
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine.
    Kölzer M; Werth N; Sandhoff K
    FEBS Lett; 2004 Feb; 559(1-3):96-8. PubMed ID: 14960314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.